Quick Takeaways
- Gil M. Labrucherie has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,737,920.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Gil M. Labrucherie
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Gil M. Labrucherie is at least $1,737,920 dollars as of 10 Feb 2026. Gil M. Labrucherie is the Director of Rezolute, Inc. and owns shares of Rezolute, Inc. (RZLT) stock worth about $1M. Gil M. Labrucherie is the CFO and CBO of ACELYRIN, Inc. and owns shares of ACELYRIN, Inc. stock worth about $348.2K. Gil M. Labrucherie is the Chief Financial Officer of Septerna, Inc. and owns shares of Septerna, Inc. (SEPN) stock worth about $234K. Gil M. Labrucherie is the SVP, COO & CFO of NEKTAR THERAPEUTICS and owns shares of NEKTAR THERAPEUTICS (NKTR) stock worth about $153.3K.
- Signature
- /s/ Mark A. Wilson, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gil M. Labrucherie and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Rezolute, Inc. ($1,002,371).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Gil M. Labrucherie
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | Director | $1,002,371 | 19 Nov 2025 | ||
| SLRN | ACELYRIN, Inc. | CFO and CBO | $348,226 | 31 Aug 2024 | ||
| SEPN | Septerna, Inc. | Chief Financial Officer | $234,000 | 06 Feb 2026 | ||
| NKTR | NEKTAR THERAPEUTICS | Svp, Coo & Cfo | $153,323 | 15 May 2022 |
Insider Transactions Reported by Gil M. Labrucherie:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.